Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 25, Pages 17954-17967
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-05-08
DOI
10.1074/jbc.m113.475277
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells
- (2013) Anastasios I. Tsonis et al. FEBS Journal
- Syndecan Binding Protein (SDCBP) Is Overexpressed in Estrogen Receptor Negative Breast Cancers, and Is a Potential Promoter for Tumor Proliferation
- (2013) Xiao-Long Qian et al. PLoS One
- Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism
- (2012) Sherif A. Ibrahim et al. INTERNATIONAL JOURNAL OF CANCER
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer
- (2012) M K Wendt et al. ONCOGENE
- Targeting EGFR in Triple Negative Breast Cancer
- (2012) Naoto T. Ueno et al. Journal of Cancer
- Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
- (2011) Stacey L Fossey et al. BMC CANCER
- CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
- (2011) Michael O. Idowu et al. HUMAN PATHOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
- (2011) Michael K. Wendt et al. MOLECULAR BIOLOGY OF THE CELL
- β3 Integrin–EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells
- (2011) Nikolas Balanis et al. MOLECULAR BIOLOGY OF THE CELL
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors
- (2011) Caroline Rousseau et al. EJNMMI Research
- Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
- (2010) Dalit Barkan et al. EUROPEAN JOURNAL OF CANCER
- Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition
- (2010) Melissa G. Mendez et al. FASEB JOURNAL
- Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
- (2010) M K Wendt et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Signal co-operation between integrins and other receptor systems
- (2009) Charles H. Streuli et al. BIOCHEMICAL JOURNAL
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Cetuximab/C225-Induced Intracellular Trafficking of Epidermal Growth Factor Receptor
- (2009) H.-J. Liao et al. CANCER RESEARCH
- Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells
- (2009) Robert X.-D. Song et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Integrin 1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs
- (2009) T. Shibue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer
- (2009) John F. Flynn et al. Journal of Oncology
- Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
- (2008) D. Barkan et al. CANCER RESEARCH
- TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4
- (2008) David Padua et al. CELL
- A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer
- (2008) M. N. Dickler et al. CLINICAL CANCER RESEARCH
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now